相似文献
1
Hippo activation in arrhythmogenic cardiomyopathy.
Circ Res. 2014 Jan 31;114(3):402-5. doi: 10.1161/CIRCRESAHA.113.303114.
2
The hippo pathway is activated and is a causal mechanism for adipogenesis in arrhythmogenic cardiomyopathy.
Circ Res. 2014 Jan 31;114(3):454-68. doi: 10.1161/CIRCRESAHA.114.302810. Epub 2013 Nov 25.
3
Genetic and epigenetic regulation of arrhythmogenic cardiomyopathy.
Biochim Biophys Acta Mol Basis Dis. 2017 Aug;1863(8):2064-2069. doi: 10.1016/j.bbadis.2017.04.020. Epub 2017 Apr 25.
4
Genetic fate mapping identifies second heart field progenitor cells as a source of adipocytes in arrhythmogenic right ventricular cardiomyopathy.
Circ Res. 2009 May 8;104(9):1076-84. doi: 10.1161/CIRCRESAHA.109.196899. Epub 2009 Apr 9.
5
Molecular mechanisms of arrhythmogenic cardiomyopathy.
Nat Rev Cardiol. 2019 Sep;16(9):519-537. doi: 10.1038/s41569-019-0200-7.
6
Profiling of differentially expressed microRNAs in arrhythmogenic right ventricular cardiomyopathy.
Sci Rep. 2016 Jun 16;6:28101. doi: 10.1038/srep28101.
7
Arrhythmogenic Cardiomyopathy: the Guilty Party in Adipogenesis.
J Cardiovasc Transl Res. 2017 Dec;10(5-6):446-454. doi: 10.1007/s12265-017-9767-8. Epub 2017 Oct 5.
8
Arrhythmogenic right ventricular cardiomyopathy: new insights into mechanisms of disease.
Cardiovasc Pathol. 2010 May-Jun;19(3):166-70. doi: 10.1016/j.carpath.2009.10.006. Epub 2010 Jan 6.
9
Reconciling the protean manifestations of arrhythmogenic cardiomyopathy.
Circ Arrhythm Electrophysiol. 2010 Dec;3(6):566-70. doi: 10.1161/CIRCEP.110.960237.
10
Distinct molecular signature of phospholamban p.Arg14del arrhythmogenic cardiomyopathy.
Cardiovasc Pathol. 2019 May-Jun;40:2-6. doi: 10.1016/j.carpath.2018.12.006. Epub 2018 Dec 21.
引用本文的文献
1
Targeting Canonical Wnt-signaling Through GSK-3β in Arrhythmogenic Cardiomyopathy: Conservative or Progressive?
J Cardiovasc Transl Res. 2025 Feb;18(1):121-132. doi: 10.1007/s12265-024-10567-x. Epub 2024 Oct 11.
2
Continuous live imaging reveals a subtle pathological alteration with cell behaviors in congenital heart malformation.
Fundam Res. 2021 Dec 3;2(1):14-22. doi: 10.1016/j.fmre.2021.11.025. eCollection 2022 Jan.
3
Desmosomes in Cell Fate Determination: From Cardiogenesis to Cardiomyopathy.
Cells. 2023 Aug 22;12(17):2122. doi: 10.3390/cells12172122.
4
Arrhythmogenic cardiomyopathy as a myogenic disease: highlights from cardiomyocytes derived from human induced pluripotent stem cells.
Front Physiol. 2023 May 11;14:1191965. doi: 10.3389/fphys.2023.1191965. eCollection 2023.
5
Mechanotransduction regulates inflammation responses of epicardial adipocytes in cardiovascular diseases.
Front Endocrinol (Lausanne). 2022 Dec 16;13:1080383. doi: 10.3389/fendo.2022.1080383. eCollection 2022.
6
Non Coding RNAs as Regulators of Wnt/β-Catenin and Hippo Pathways in Arrhythmogenic Cardiomyopathy.
Biomedicines. 2022 Oct 18;10(10):2619. doi: 10.3390/biomedicines10102619.
7
Spatial transcriptomics unveils ZBTB11 as a regulator of cardiomyocyte degeneration in arrhythmogenic cardiomyopathy.
Cardiovasc Res. 2023 Mar 31;119(2):477-491. doi: 10.1093/cvr/cvac072.
8
Molecular Basis of Inflammation in the Pathogenesis of Cardiomyopathies.
Int J Mol Sci. 2020 Sep 4;21(18):6462. doi: 10.3390/ijms21186462.
9
Knockout of SORBS2 Protein Disrupts the Structural Integrity of Intercalated Disc and Manifests Features of Arrhythmogenic Cardiomyopathy.
J Am Heart Assoc. 2020 Sep;9(17):e017055. doi: 10.1161/JAHA.119.017055. Epub 2020 Aug 18.
10
Intercalated discs: cellular adhesion and signaling in heart health and diseases.
Heart Fail Rev. 2019 Jan;24(1):115-132. doi: 10.1007/s10741-018-9743-7.
本文引用的文献
1
The hippo pathway is activated and is a causal mechanism for adipogenesis in arrhythmogenic cardiomyopathy.
Circ Res. 2014 Jan 31;114(3):454-68. doi: 10.1161/CIRCRESAHA.114.302810. Epub 2013 Nov 25.
2
Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1/2 protein kinases.
Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17368-73. doi: 10.1073/pnas.1308236110. Epub 2013 Oct 7.
3
Plakoglobin as a regulator of desmocollin gene expression.
J Invest Dermatol. 2013 Dec;133(12):2732-2740. doi: 10.1038/jid.2013.220. Epub 2013 May 7.
4
Genetics of arrhythmogenic right ventricular cardiomyopathy.
J Med Genet. 2013 May;50(5):280-9. doi: 10.1136/jmedgenet-2013-101523. Epub 2013 Mar 6.
5
Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs.
Nature. 2013 Feb 7;494(7435):105-10. doi: 10.1038/nature11799. Epub 2013 Jan 27.
6
β-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis.
Cell. 2012 Dec 21;151(7):1457-73. doi: 10.1016/j.cell.2012.11.026. Epub 2012 Dec 13.
7
Arrhythmogenic right ventricular cardiomyopathy: an update on pathophysiology, genetics, diagnosis, and risk stratification.
Herzschrittmacherther Elektrophysiol. 2012 Sep;23(3):186-95. doi: 10.1007/s00399-012-0233-7. Epub 2012 Sep 26.
8
YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy.
Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2394-9. doi: 10.1073/pnas.1116136109. Epub 2012 Jan 30.
9
Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size.
Sci Signal. 2011 Oct 25;4(196):ra70. doi: 10.1126/scisignal.2002278.
10
Nuclear plakoglobin is essential for differentiation of cardiac progenitor cells to adipocytes in arrhythmogenic right ventricular cardiomyopathy.
Circ Res. 2011 Dec 9;109(12):1342-53. doi: 10.1161/CIRCRESAHA.111.255075. Epub 2011 Oct 20.
Zotero 插件